Lymphoma, Low-Grade Completed Phase 2 Trials for Fludarabine (DB01073)

Also known as: Low-Grade Lymphoma

Indication	Status	Phase
DBCOND0029914 (Lymphoma, Low-Grade)	Completed	2

clinicaltrials.gov Identifier	Title	Purpose	Drugs
NCT00311129	Efficacy and Safety Study of SH T 586 in Combination With Rituximab to Treat Low-Grade NHL	Treatment	Fludarabine (DB01073) Rituximab (DB00073)
NCT01181271	Tandem Auto-Allo Transplant for Lymphoma	Treatment	Busulfan (DB01008) Coenzyme M (DB09110) Cyclophosphamide (DB00531) Etoposide (DB00773) Filgrastim (DB00099) Fludarabine (DB01073) Methotrexate (DB00563) Sirolimus (DB00877) Tacrolimus (DB00864)